IDEXX Laboratories Inc (IDXX) stock
IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3036% above fair value
$690.24−10.41 (-1.49%)
Close on Nov 17, 2026Market cap $54.38BP/E 48.5Yield –
IDEXX Laboratories enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
IDEXX Laboratories's enterprise value was $55.67B on Nov 11, 2026, against $60.55B a year earlier. Over the last 5 years it ranged from $27.83B to $60.55B, with a median of $41.96B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $55.67B | +2.3% |
| 2025 | Dec 31, 2025 | $54.44B | +59.0% |
| 2024 | Dec 31, 2024 | $34.23B | -26.5% |
| 2023 | Dec 29, 2023 | $46.54B | +34.8% |
| 2022 | Dec 30, 2022 | $34.52B | -39.0% |
| 2021 | Dec 31, 2021 | $56.60B | +30.5% |
| 2020 | Dec 31, 2020 | $43.37B | +94.3% |
| 2019 | Dec 31, 2019 | $22.32B | +39.9% |
| 2018 | Dec 31, 2018 | $15.95B | +17.2% |
| 2017 | Dec 29, 2017 | $13.61B | +32.2% |
| 2016 | Dec 30, 2016 | $10.30B | +63.4% |
| 2015 | Dec 31, 2015 | $6.30B | -14.8% |
| 2014 | Dec 31, 2014 | $7.39B | +33.0% |
| 2013 | Dec 31, 2013 | $5.56B | +10.8% |
| 2012 | Dec 31, 2012 | $5.01B | +15.6% |
| 2011 | Dec 30, 2011 | $4.34B | +8.2% |
| 2010 | Dec 31, 2010 | $4.01B | +23.5% |
| 2009 | Dec 31, 2009 | $3.25B | – |
See a number that looks wrong?